$ONFO
Onfolio Holdings, Inc Stock $onfo

$onfo Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000165495423014353 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$1.265M	$1.313M
YoY Change	12.56%	272.78%
Cost Of Revenue	$428.6K	$465.6K
YoY Change	15.32%	114.71%
Gross Profit	$836.3K	$847.7K
YoY Change	11.19%	525.82%
Gross Profit Margin	66.12%	64.55%
Selling, General & Admin	$1.633M	$1.532M
YoY Change	18.36%	57.14%
% of Gross Profit	195.24%	180.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$189.8K	$190.0K
YoY Change	52.03%
% of Gross Profit	22.69%	22.41%
Operating Expenses	$1.633M	$5.588M
YoY Change	18.36%	397.34%
Operating Profit	-$796.5K	-$4.741M
YoY Change	26.95%	379.73%
Interest Expense	$4.320K	$10.00K
YoY Change	-61.15%	265.1%
% of Operating Profit
Other Income/Expense, Net	$0.00	$7.464K
YoY Change	-100.0%
Pretax Income	-$833.5K	-$4.733M
YoY Change	-33.4%	388.11%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$905.3K	-$4.733M
YoY Change	-30.85%	388.11%
Net Earnings / Revenue	-71.57%	-360.4%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.18	-$0.94
COMMON SHARES
Basic Shares Outstanding	5.110M shares	5.110M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$982.3K	$3.370M
YoY Change	-85.34%	-70.99%
Cash & Equivalents	$982.3K	$3.373M
Short-Term Investments
Other Short-Term Assets	$111.1K	$120.0K
YoY Change	-47.64%	-57.14%
Inventory	$92.64K	$114.5K
Prepaid Expenses
Receivables	$90.07K	$97.52K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.276M	$3.707M
YoY Change	-82.17%	-69.13%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$1.167M	$1.166M
YoY Change	-72.27%
Intangibles	$3.110M	$3.280M
YoY Change	-19.52%
Long-Term Investments	$427.1K	$274.8K
YoY Change	-1.68%	-37.89%
Other Assets	$151.0K	$160.0K
YoY Change	35.13%	24.45%
Total Long-Term Assets	$4.855M	$5.032M
YoY Change	-43.67%	167.75%
TOTAL ASSETS
Total Short-Term Assets	$1.276M	$3.707M
Total Long-Term Assets	$4.855M	$5.032M
Total Assets	$6.131M	$8.738M
YoY Change	-61.13%	-37.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$493.8K	$430.0K
YoY Change	-10.29%	64.3%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$17.32K	$2.420M
YoY Change	-99.29%	13872.29%
Total Short-Term Liabilities	$789.1K	$3.186M
YoY Change	-76.11%	810.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$789.1K	$3.186M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$789.1K	$3.186M
YoY Change	-76.11%	810.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.95M	-$15.05M
YoY Change	110.44%	139.94%
Common Stock	$413.2K	$418.2K
YoY Change	-1.2%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.342M	$5.553M
YoY Change
Total Liabilities & Shareholders Equity	$6.131M	$8.738M
YoY Change	-61.13%	-37.08%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$905.3K	-$4.733M
YoY Change	-30.85%	388.11%
Depreciation, Depletion And Amortization	$189.8K	$190.0K
YoY Change	52.03%
Cash From Operating Activities	-$591.8K	-$600.0K
YoY Change	19.02%	-25.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%
Cash From Investing Activities	$0.00	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.887M	-70.00K
YoY Change	1191.25%	-100.58%
NET CHANGE
Cash From Operating Activities	-591.8K	-600.0K
Cash From Investing Activities	0.000	0.000
Cash From Financing Activities	-1.887M	-70.00K
Net Change In Cash	-2.478M	-670.0K
YoY Change	-49.93%	-105.99%
FREE CASH FLOW
Cash From Operating Activities	-$591.8K	-$600.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	155500	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4787390	usd
	onfolio	Weighted Average Grant Date Fair Value Granted WeightedAverageGrantDateFairValueGranted	0.93
	onfolio	Weighted Average Grant Date Fair Value Forfeited And Cancelled WeightedAverageGrantDateFairValueForfeitedAndCancelled	-3.69
CY2022Q3	us-gaap	Management Fee Expense ManagementFeeExpense	54637	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001825452
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5110195	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5110195	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5110195	shares
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1	pure
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	30045	usd
CY2022Q2	us-gaap	Management Fee Expense ManagementFeeExpense	50237	usd
CY2023Q2	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	usd
CY2022Q2	us-gaap	Impairment Of Investments ImpairmentOfInvestments	29557	usd
	onfolio	Weighted Average Grant Date Fair Value Exercised WeightedAverageGrantDateFairValueExercised	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	383328	usd
	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	383328	usd
	onfolio	Warrant Exercise Price WarrantExercisePrice	5.00
CY2022Q4	onfolio	Due To Related Parties Included In Current Liabilities DueToRelatedPartiesIncludedInCurrentLiabilities	36994	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41466
	dei	Entity Registrant Name EntityRegistrantName	ONFOLIO HOLDINGS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1978697
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1007 North Orange Street, 4th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wilmington
	dei	Entity Address State Or Province EntityAddressStateOrProvince	DE
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19801
	dei	City Area Code CityAreaCode	682
	dei	Local Phone Number LocalPhoneNumber	990-6920
	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	ONFO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5110195	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3373178	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6701122	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	97522	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	137598	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	114492	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	105129	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	121557	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	212180	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	3706749	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7156029	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3280243	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3864618	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1165636	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4209126	usd
CY2023Q3	onfolio	Due From Related Party DueFromRelatedParty	156952	usd
CY2022Q4	onfolio	Due From Related Party DueFromRelatedParty	111720	usd
CY2023Q3	onfolio	Total Cost Method Investments TotalCostMethodInvestments	154007	usd
CY2022Q4	onfolio	Total Cost Method Investments TotalCostMethodInvestments	154007	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	274774	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	280326	usd
CY2023Q3	us-gaap	Assets Assets	8738361	usd
CY2022Q4	us-gaap	Assets Assets	15775826	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	431189	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	550454	usd
CY2023Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	49341	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	54404	usd
CY2023Q3	onfolio	Acquisition Notes Payable Current AcquisitionNotesPayableCurrent	2416323	usd
CY2022Q4	onfolio	Acquisition Notes Payable Current AcquisitionNotesPayableCurrent	2456323	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	68959	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	60000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	60000	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	228960	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	113251	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3185813	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3303391	usd
CY2023Q3	us-gaap	Liabilities Liabilities	3185813	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3303391	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5110195	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	5110	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5110	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20520807	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19950774	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	73910	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	96971	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15047349	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7580490	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	5552548	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12472435	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8738361	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15775826	usd
CY2023Q3	onfolio	Revenue Services RevenueServices	433490	usd
CY2022Q3	onfolio	Revenue Services RevenueServices	59032	usd
	onfolio	Revenue Services RevenueServices	1121641	usd
	onfolio	Revenue Services RevenueServices	245162	usd
CY2023Q3	onfolio	Revenue Product Sales RevenueProductSales	879821	usd
CY2022Q3	onfolio	Revenue Product Sales RevenueProductSales	293268	usd
	onfolio	Revenue Product Sales RevenueProductSales	2853447	usd
	onfolio	Revenue Product Sales RevenueProductSales	850883	usd
CY2023Q3	us-gaap	Revenues Revenues	1313311	usd
CY2022Q3	us-gaap	Revenues Revenues	352300	usd
	us-gaap	Revenues Revenues	3975088	usd
	us-gaap	Revenues Revenues	1096046	usd
CY2023Q3	onfolio	Cost Of Revenue Services CostOfRevenueServices	218063	usd
CY2022Q3	onfolio	Cost Of Revenue Services CostOfRevenueServices	100961	usd
	onfolio	Cost Of Revenue Services CostOfRevenueServices	651849	usd
	onfolio	Cost Of Revenue Services CostOfRevenueServices	284716	usd
CY2023Q3	onfolio	Cost Of Revenue Product Sales CostOfRevenueProductSales	247533	usd
CY2022Q3	onfolio	Cost Of Revenue Product Sales CostOfRevenueProductSales	115883	usd
	onfolio	Cost Of Revenue Product Sales CostOfRevenueProductSales	916740	usd
	onfolio	Cost Of Revenue Product Sales CostOfRevenueProductSales	365010	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	465596	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	216844	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1568589	usd
	us-gaap	Cost Of Revenue CostOfRevenue	649726	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	847715	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	135457	usd
	us-gaap	Gross Profit GrossProfit	2406499	usd
	us-gaap	Gross Profit GrossProfit	446320	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1532152	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	974998	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4724357	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2744751	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	216082	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	148649	usd
	us-gaap	Professional Fees ProfessionalFees	843910	usd
	us-gaap	Professional Fees ProfessionalFees	417032	usd
CY2023Q3	onfolio	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	3762579	usd
CY2022Q3	onfolio	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	0	usd
	onfolio	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	3952516	usd
	onfolio	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	0	usd
CY2023Q3	us-gaap	Acquisition Costs AcquisitionCosts	77525	usd
CY2022Q3	us-gaap	Acquisition Costs AcquisitionCosts	0	usd
	us-gaap	Acquisition Costs AcquisitionCosts	285532	usd
	us-gaap	Acquisition Costs AcquisitionCosts	240468	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	5588338	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1123647	usd
	us-gaap	Operating Expenses OperatingExpenses	9806315	usd
	us-gaap	Operating Expenses OperatingExpenses	3402251	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4740623	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-988190	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7399816	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2955931	usd
CY2023Q3	onfolio	Equity Method Income EquityMethodIncome	2826	usd
CY2022Q3	onfolio	Equity Method Income EquityMethodIncome	9568	usd
	onfolio	Equity Method Income EquityMethodIncome	14921	usd
	onfolio	Equity Method Income EquityMethodIncome	26056	usd
CY2023Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	94	usd
CY2022Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	574	usd
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	1610	usd
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	2292	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10231	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2739	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	68989	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3995	usd
CY2023Q3	us-gaap	Other Income OtherIncome	-5687	usd
CY2022Q3	us-gaap	Other Income OtherIncome	11091	usd
	us-gaap	Other Income OtherIncome	2937	usd
	us-gaap	Other Income OtherIncome	12445	usd
CY2023Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	usd
CY2022Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	usd
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	usd
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	29557	usd
CY2023Q3	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
CY2022Q3	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-34306	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7464	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18494	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	88457	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-27065	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4733159	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-969696	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7311359	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2982996	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-4733159	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-969696	usd
	us-gaap	Profit Loss ProfitLoss	-7311359	usd
	us-gaap	Profit Loss ProfitLoss	-2982996	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	54231	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	88848	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1310262	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7466859	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3071844	usd
CY2023Q3	onfolio	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.94
CY2022Q3	onfolio	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.30
	onfolio	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-1.46
	onfolio	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-1.15
CY2023Q3	onfolio	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	5110195	shares
CY2022Q3	onfolio	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	3284339	shares
	onfolio	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	5110195	shares
	onfolio	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	2675634	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12472435	usd
CY2023Q1	onfolio	Stock Based Compensation StockBasedCompensation	233355	usd
CY2023Q1	onfolio	Preferred Dividends PreferredDividends	-51025	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7481	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1284075	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11363209	usd
CY2023Q2	onfolio	Stock Based Compensation StockBasedCompensation	250242	usd
CY2023Q2	onfolio	Preferred Dividends PreferredDividends	-50244	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	20067	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	10289149	usd
CY2023Q3	onfolio	Stock Based Compensation StockBasedCompensation	86436	usd
CY2023Q3	onfolio	Preferred Dividends PreferredDividends	-54231	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-35647	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4733159	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	5552548	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3373805	usd
CY2022Q1	onfolio	Preferred Shares For Cash Amount PreferredSharesForCashAmount	130000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	219660	usd
CY2022Q1	onfolio	Preferred Dividends PreferredDividends	-43120	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-748766	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	2931579	usd
CY2022Q2	onfolio	Preferred Shares For Cash Amount PreferredSharesForCashAmount	186500	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	240185	usd
CY2022Q2	onfolio	Preferred Dividends PreferredDividends	-45728	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2048002	usd
CY2022Q3	onfolio	Preferred Shares For Cash Amount PreferredSharesForCashAmount	5000	usd
CY2022Q3	onfolio	Common Stock Issued Initial Public Offering Amount CommonStockIssuedInitialPublicOfferingAmount	12255470	usd
CY2022Q3	onfolio	Stock Based Compensation StockBasedCompensation	247706	usd
CY2022Q3	onfolio	Preferred Dividends PreferredDividends	-48457	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1264534	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	2048002	usd
	us-gaap	Profit Loss ProfitLoss	-7311359	usd
	us-gaap	Profit Loss ProfitLoss	-2982996	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	570033	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	701551	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14921	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-26056	usd
	onfolio	Dividends Received From Equity Method Investment DividendsReceivedFromEquityMethodInvestment	20473	usd
	onfolio	Dividends Received From Equity Method Investment DividendsReceivedFromEquityMethodInvestment	23915	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-34306	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	549914	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3952516	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	40076	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4491	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9363	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4058	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	90623	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-120214	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-119265	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	39163	usd
	onfolio	Increase Decrease In Due To Joint Ventures IncreaseDecreaseInDueToJointVentures	-45232	usd
	onfolio	Increase Decrease In Due To Joint Ventures IncreaseDecreaseInDueToJointVentures	-26561	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	115709	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-21802	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-480	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2160796	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2373607	usd
	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	0	usd
	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	45694	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	850000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0	usd
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	22500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-850000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	23194	usd
	onfolio	Proceeds From Sale Of Series A Preferred Stock ProceedsFromSaleOfSeriesAPreferredStock	0	usd
	onfolio	Proceeds From Sale Of Series A Preferred Stock ProceedsFromSaleOfSeriesAPreferredStock	321500	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12255470	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	160563	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	91264	usd
	onfolio	Payment Of Contribution To Joint Venture Note Payable PaymentOfContributionToJointVentureNotePayable	0	usd
	onfolio	Payment Of Contribution To Joint Venture Note Payable PaymentOfContributionToJointVentureNotePayable	-215000	usd
	onfolio	Payments On Acquisition Note Payable PaymentsOnAcquisitionNotePayable	40000	usd
	onfolio	Payments On Acquisition Note Payable PaymentsOnAcquisitionNotePayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	44000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	68959	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	59228	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-269522	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12255478	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-47626	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3327944	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9905065	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6701122	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1710318	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3373178	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11615383	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	61141	usd
	us-gaap	Interest Paid Net InterestPaidNet	5493	usd
	us-gaap	Variable Interest Entity Ownership Percentage VariableInterestEntityOwnershipPercentage	0.50	pure
	us-gaap	Investment Company Total Return Payment To Fund By Affiliate InvestmentCompanyTotalReturnPaymentToFundByAffiliate	0.358	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the balance sheet. The Company uses significant judgements when making estimates related to the assessment of control over variable interest entities, valuation of deferred tax assets and impairment of long lived assets. Actual results could differ from those estimates.</p>
CY2023Q3	onfolio	Deferred Revenues DeferredRevenues	228960	usd
CY2023Q3	us-gaap	Management Fee Expense ManagementFeeExpense	30921	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	101578	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	170976	usd
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	592782	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	4396	usd
	us-gaap	Advertising Expense AdvertisingExpense	1020063	usd
	us-gaap	Advertising Expense AdvertisingExpense	74186	usd
CY2023Q3	us-gaap	Production Costs ProductionCosts	179764	usd
CY2022Q3	us-gaap	Production Costs ProductionCosts	196190	usd
	us-gaap	Production Costs ProductionCosts	488254	usd
	us-gaap	Production Costs ProductionCosts	528185	usd
CY2023Q3	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	509844	usd
CY2022Q3	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	97077	usd
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	2365193	usd
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	322699	usd
CY2023Q3	us-gaap	Revenues Revenues	1313311	usd
CY2022Q3	us-gaap	Revenues Revenues	352300	usd
	us-gaap	Revenues Revenues	3975088	usd
	us-gaap	Revenues Revenues	1096046	usd
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.10	pure
	onfolio	Cost Of Revenue Policytextblock CostOfRevenuePolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cost of product revenue consists primarily of costs associated with the acquisition and shipment of products being sold through the Company’s online marketplaces, and the costs of its service revenue, which include website content creation costs including contract labor, service fulfillment, domain and hosting costs and certain software costs related to website operations.</p>
	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.50	pure
	onfolio	Purchase Price Paid PurchasePricePaid	850000	usd
CY2023Q3	us-gaap	Amortization Expense Per Dollar Of Gross Revenue AmortizationExpensePerDollarOfGrossRevenue	141667	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3864618	usd
CY2022Q4	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	512000	usd
CY2023Q3	onfolio	Revenue In Joint Venture RevenueInJointVenture	9404	usd
CY2022Q3	onfolio	Revenue In Joint Venture RevenueInJointVenture	28008	usd
	onfolio	Revenue In Joint Venture RevenueInJointVenture	48169	usd
	onfolio	Revenue In Joint Venture RevenueInJointVenture	81777	usd
CY2023Q3	us-gaap	Net Investment Income NetInvestmentIncome	7895	usd
CY2022Q3	us-gaap	Net Investment Income NetInvestmentIncome	26740	usd
	us-gaap	Net Investment Income NetInvestmentIncome	41680	usd
	us-gaap	Net Investment Income NetInvestmentIncome	69115	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3953982	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3989450	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3280243	usd
CY2022Q4	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	1443000	usd
CY2022Q4	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	692000	usd
CY2023Q1	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	850000	usd
CY2023Q1	onfolio	Finite Lived Intangible Assets Remaining Amortization Period One FiniteLivedIntangibleAssetsRemainingAmortizationPeriodOne	P4Y
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3952516	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	231355	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	756419	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	742377	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	628664	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	186562	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	316543	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2861920	usd
CY2022	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	12860	shares
CY2022	onfolio	Proceeds From Customers1 ProceedsFromCustomers1	321500	usd
CY2021	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	56600	shares
CY2021	onfolio	Proceeds From Customers1 ProceedsFromCustomers1	1415000	usd
	us-gaap	Dividends Dividends	155500	usd
	us-gaap	Dividends Dividends	88848	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	160563	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	91264	usd
CY2023Q3	onfolio	Unpaid Dividends UnpaidDividends	49341	usd
CY2022Q4	onfolio	Unpaid Dividends UnpaidDividends	54404	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q3	onfolio	Warrant Exercise Price WarrantExercisePrice	5.00
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	onfolio	Warrant Exercise Price WarrantExercisePrice	5.00
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	413063	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	826126	usd
	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.15	pure
	onfolio	Description Of Additional Warrants DescriptionOfAdditionalWarrants	On August 29, 2022, the underwriter partially exercised this option and purchased 609,750 additional warrants at the purchase price of $.01 per warrant for aggregate gross proceeds of $6,097.50
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	82613	usd
	onfolio	Warrant Exercise Price WarrantExercisePrice	5.50
	us-gaap	Public Utilities Interim Rate Increase Decrease Percentage PublicUtilitiesInterimRateIncreaseDecreasePercentage	1.10	pure
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	2753750	shares
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5507500	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	13774848	usd
CY2022Q3	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	12225470	usd
CY2020Q4	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3233336	usd
	onfolio	Shares Awarded To The Company Board Of Directors SharesAwardedToTheCompanyBoardOfDirectors	2800	shares
	onfolio	Stock Based Compensation Fair Value StockBasedCompensationFairValue	16667	usd
	us-gaap	Key Provisions Of Operating Or Partnership Agreement Description KeyProvisionsOfOperatingOrPartnershipAgreementDescription	The Company estimated fair value of these options to be $0.93 per share using a Black-Scholes option pricing model, and the expense associated with the options will be recognized over the requite service period of 7 months
	onfolio	Description Of Black Scholes Option Pricing Model DescriptionOfBlackScholesOptionPricingModel	the following assumptions: 1) dividend yield of 0%; 2) risk-free rate of 3.70%; 3) volatility of 209.7% based on a group of peer group companies; 4) a common stock price of $1.27 based on the most recent common stock sales for cash, and 5) an expected term of five years
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	59850	shares
CY2022Q4	onfolio	Weighted Average Grant Date Fair Valueending WeightedAverageGrantDateFairValueending	4.15
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.11
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	60000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.27
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	22661	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.68
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	97189	shares
CY2023Q3	onfolio	Weighted Average Grant Date Fair Valueending WeightedAverageGrantDateFairValueending	2.25
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.21
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	81932	shares
CY2023Q3	onfolio	Weighted Average Grant Date Fair Valueexercisable WeightedAverageGrantDateFairValueexercisable	2.35
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.23
	us-gaap	Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1 NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1	P6Y6M
	us-gaap	Officers Compensation OfficersCompensation	32267	usd
CY2023Q3	onfolio	Due From Related Parties Included In Non Current Assets DueFromRelatedPartiesIncludedInNonCurrentAssets	119958	usd
CY2022Q4	onfolio	Due From Related Parties Included In Non Current Assets DueFromRelatedPartiesIncludedInNonCurrentAssets	74866	usd
CY2023Q3	onfolio	Due To Related Parties Included In Current Liabilities DueToRelatedPartiesIncludedInCurrentLiabilities	36994	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	82490	usd
CY2022Q4	us-gaap	Cash Cash	73000	usd
CY2022Q4	us-gaap	Public Utilities Approved Rate Increase Decrease Percentage PublicUtilitiesApprovedRateIncreaseDecreasePercentage	0.17	pure
CY2023Q3	onfolio	Company Owed CompanyOwed	0	usd
CY2022Q4	onfolio	Company Owed CompanyOwed	68959	usd
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2399000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
onfolio-20230930_pre.xml	Edgar Link	unprocessable
0001654954-23-014353-index-headers.html	Edgar Link	pending
0001654954-23-014353-index.html	Edgar Link	pending
0001654954-23-014353.txt	Edgar Link	pending
0001654954-23-014353-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
onfolio-20230930.xsd	Edgar Link	pending
onfolio_10q.htm	Edgar Link	pending
onfolio_ex311.htm	Edgar Link	pending
onfolio_ex312.htm	Edgar Link	pending
onfolio_ex321.htm	Edgar Link	pending
onfolio_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
onfolio-20230930_cal.xml	Edgar Link	unprocessable
onfolio-20230930_def.xml	Edgar Link	unprocessable
onfolio-20230930_lab.xml	Edgar Link	unprocessable
onfolio_10q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONFO
Onfolio Holdings, Inc Stock $onfo

2023 Q4 Form 10-Q Financial Statement

#000165495423014353 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONFO Onfolio Holdings, Inc Stock $onfo

2023 Q4 Form 10-Q Financial Statement

#000165495423014353 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONFO
Onfolio Holdings, Inc Stock $onfo